Drug · DIN 02462680
TEPADINA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 6, 2017; first marketed November 6, 2017.
- Drug Identification Number (DIN)
- 02462680
- Company (DIN owner)
- Adienne SaLugano, Tessin, Switzerland
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Thiotepa L01AC01
- Class
- Human
- Record last updated
- April 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| THIOTEPA | 15 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 29, 2017: NOC 19108New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “tepadina”. A notice may cover another product or only some lots: read it to see what it covers.
- Tepadina (2020-05-08)May 8, 2020 · Drugs · Product safety · Type I
Other DINs named TEPADINA
- DIN 02462702 · Marketed
- DIN 02523906 · Dormant
- DIN 02567059 · Approved